世界の高リン酸血症治療薬市場は、2022年に約12億3,000万米ドルと評価され、2023年から2030年の予測期間にわたって8.2％を超える健全な成長率で成長すると予想されています。高リン酸血症の治療は、慢性腎臓病（CKD）やその他の腎疾患に関連することが多い血中のリン酸塩レベルの上昇を管理することを目的としています。治療法には通常、リン酸塩の摂取を制限する食事の修正、胃腸管での吸収を抑えるリン酸塩結合剤、腎臓からのリン酸塩の排泄を促進する薬物療法が含まれます。カルシウムベースまたは非カルシウムベースの薬剤などのリン酸塩結合剤は、腸内で食事のリン酸塩に結合し、血流への吸収を防ぐことでリン酸塩レベルを下げるのに役立ちます。さらに、腸内でのリン酸塩の吸収を減らすために、テナパノールなどの薬剤が使用されることもあります。透析は、血液から過剰なリン酸塩を除去するために進行したCKD段階でよく使用されます。治療法の選択は、高リン血症の重症度、基礎となる腎機能、および個々の患者の要因によって異なります。リン酸塩のモニタリングとリン酸塩レベルの管理は、心血管疾患、骨疾患、軟組織の石灰化などの合併症を防ぐために非常に重要です。高リン血症治療薬市場は、国民の意識の高まりと診断能力の向上、腎臓透析の増加、高齢化の増加や薬物療法の進歩などの要因により拡大しています。
さらに、慢性腎臓病（CKD）の有病率の上昇により、効率的な高リン血症治療の必要性が高まっており、これが世界中の市場成長の触媒要因として機能しています。たとえば、2023 年に米国疾病管理予防センター（CDC）は、アメリカの人口の 14% に相当する3,550 万人がCKDに罹患していると報告しました。高リン血症はCKD患者や透析患者の間で蔓延しています。したがって、これらの症状による負荷の増加は、高リン酸血症の発生の増加と相関しています。よって、これらの前述の要因は、推定期間中の高リン血症治療薬市場の成長を推進しています。さらに、革新的な高リン血症治療の選択肢の開発の増加と、償還政策の実施の増加により、予測期間にさまざまな有利な機会がもたらされます。ただし、高リン血症治療薬の使用による合併症と医療アドヒアランスの低下が、2023年から2030年の予測期間を通じて市場の成長に課題をもたらしています。
世界の高リン酸血症治療薬市場調査で考慮される主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。透析を受けているCKD患者数の増加により、2022年には北アメリカが市場を独占しました。2023年5月に国立糖尿病・消化器・腎臓障害研究所（NIDDK）が発表したデータによると、アメリカでは約80万8,000人が末期腎疾患（ESRD）を抱えており、そのうち69％が透析を受けています。この人口動態傾向は、予測期間を通じて高リン血症治療薬の需要を著しく促進すると予想されます。一方、アジア太平洋地域は、予測期間で最高の CAGR で成長すると予想されます。先進国と比較してカルシウムベースのリン酸塩結合剤の使用が普及しているため、この地域全体の市場需要が大幅に増加しています。また、これらの地域での処方傾向の進化と、透析を受けている人口の顕著な増加は、予測期間におけるアジア太平洋地域全体の高リン血症治療の需要の高まりに大きく寄与しています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Hyperphosphatemia Therapeutics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Hyperphosphatemia Therapeutics Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Hyperphosphatemia Therapeutics Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hyperphosphatemia Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hyperphosphatemia Therapeutics Market Dynamics
3.1. Hyperphosphatemia Therapeutics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing public awareness and improved diagnostic capabilities
3.1.1.2. Rising prevalence of chronic kidney disease (CKD)
3.1.2. Market Challenges
3.1.2.1. Complications from use of hyperphosphatemia therapeutics
3.1.2.2. Poor medical adherence
3.1.3. Market Opportunities
3.1.3.1. Rising development of innovative hyperphosphatemia treatment options
3.1.3.2. Increasingly implementing reimbursement policies
Chapter 4. Global Hyperphosphatemia Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Hyperphosphatemia Therapeutics Market, by Drug Class
5.1. Market Snapshot
5.2. Global Hyperphosphatemia Therapeutics Market by Drug Class, Performance - Potential Analysis
5.3. Global Hyperphosphatemia Therapeutics Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Hyperphosphatemia Therapeutics Market, Sub Segment Analysis
5.4.1. Sevelamer
5.4.2. Calcium-based Phosphate Binders
5.4.3. Lanthanum Carbonate
5.4.4. Iron-based Phosphate Binders
5.4.5. Others
5.4.6. Non-Phosphate Binders
Chapter 6. Global Hyperphosphatemia Therapeutics Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Hyperphosphatemia Therapeutics Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Hyperphosphatemia Therapeutics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Hyperphosphatemia Therapeutics Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
Chapter 7. Global Hyperphosphatemia Therapeutics Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Hyperphosphatemia Therapeutics Market, Regional Market Snapshot
7.4. North America Hyperphosphatemia Therapeutics Market
7.4.1. U.S. Hyperphosphatemia Therapeutics Market
7.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Hyperphosphatemia Therapeutics Market
7.5. Europe Hyperphosphatemia Therapeutics Market Snapshot
7.5.1. U.K. Hyperphosphatemia Therapeutics Market
7.5.2. Germany Hyperphosphatemia Therapeutics Market
7.5.3. France Hyperphosphatemia Therapeutics Market
7.5.4. Spain Hyperphosphatemia Therapeutics Market
7.5.5. Italy Hyperphosphatemia Therapeutics Market
7.5.6. Rest of Europe Hyperphosphatemia Therapeutics Market
7.6. Asia-Pacific Hyperphosphatemia Therapeutics Market Snapshot
7.6.1. China Hyperphosphatemia Therapeutics Market
7.6.2. India Hyperphosphatemia Therapeutics Market
7.6.3. Japan Hyperphosphatemia Therapeutics Market
7.6.4. Australia Hyperphosphatemia Therapeutics Market
7.6.5. South Korea Hyperphosphatemia Therapeutics Market
7.6.6. Rest of Asia Pacific Hyperphosphatemia Therapeutics Market
7.7. Latin America Hyperphosphatemia Therapeutics Market Snapshot
7.7.1. Brazil Hyperphosphatemia Therapeutics Market
7.7.2. Mexico Hyperphosphatemia Therapeutics Market
7.8. Middle East & Africa Hyperphosphatemia Therapeutics Market
7.8.1. Saudi Arabia Hyperphosphatemia Therapeutics Market
7.8.2. South Africa Hyperphosphatemia Therapeutics Market
7.8.3. Rest of Middle East & Africa Hyperphosphatemia Therapeutics Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Sanofi SE
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Takeda Pharmaceutical Company Limited
8.3.3. Lupin Limited
8.3.4. Astellas Pharma Inc.
8.3.5. Akebia Therapeutics, Inc.
8.3.6. CSL Limited
8.3.7. Ardelyx Inc.
8.3.8. Unicycive Inc.
8.3.9. Amag Pharmaceuticals Inc
8.3.10. Akebia Therapeutics Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
List of Tables
TABLE 1. Global Hyperphosphatemia Therapeutics Market, report scope
TABLE 2. Global Hyperphosphatemia Therapeutics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Hyperphosphatemia Therapeutics Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Hyperphosphatemia Therapeutics Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Hyperphosphatemia Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Hyperphosphatemia Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Hyperphosphatemia Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Hyperphosphatemia Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Hyperphosphatemia Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Hyperphosphatemia Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Hyperphosphatemia Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Hyperphosphatemia Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Hyperphosphatemia Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Hyperphosphatemia Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Hyperphosphatemia Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Hyperphosphatemia Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Hyperphosphatemia Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Hyperphosphatemia Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Hyperphosphatemia Therapeutics Market, research methodology
FIG 2. Global Hyperphosphatemia Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Hyperphosphatemia Therapeutics Market, key trends 2022
FIG 5. Global Hyperphosphatemia Therapeutics Market, growth prospects 2023-2030
FIG 6. Global Hyperphosphatemia Therapeutics Market, porters 5 force model
FIG 7. Global Hyperphosphatemia Therapeutics Market, pest analysis
FIG 8. Global Hyperphosphatemia Therapeutics Market, value chain analysis
FIG 9. Global Hyperphosphatemia Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Hyperphosphatemia Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Hyperphosphatemia Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Hyperphosphatemia Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Hyperphosphatemia Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Hyperphosphatemia Therapeutics Market, regional snapshot 2020 & 2030
FIG 15. North America Hyperphosphatemia Therapeutics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Hyperphosphatemia Therapeutics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Hyperphosphatemia Therapeutics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Hyperphosphatemia Therapeutics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Hyperphosphatemia Therapeutics Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
